Picture of Neximmune logo

NEXI Neximmune Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Neximmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-20.5-29.9-50.9-62.5-32.3
Depreciation
Non-Cash Items1.542.933.596.394.77
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.842-0.0890.6553.93-4.88
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-19.4-26.4-45.8-51.2-31.4
Capital Expenditures-1.25-0.865-2.35-1.26-0.049
Purchase of Fixed Assets
Other Investing Cash Flow Items10.71.09-51.551.60.004
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities9.420.222-53.850.3-0.044
Financing Cash Flow Items-0.364-0.0195.150
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18.822.11255.180
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8.77-4.125.34.3-31.5